CD14 and COVID-19: There was a significantly higher percentage of CD14+CD16+ monocytes in peripheral blood from severe COVID-19 patients than in blood from mild COVID-19 patients, suggesting that pro-inflammatory monocytes might be strongly involved in the pathogenesis of the infection.